SLC25A1 and cutaneous melanoma: Moreover, Kaplan–Meier survival analysis indicated that patients with high SLC25A1 and ACLY expression in skin cutaneous melanoma (SKCM) and lung adenocarcinoma (LUAD) had shorter survival than those with low SLC25A1 and ACLY expression (Fig. 7E,F).